Microcephalin and pericentrin regulate mitotic entry via centrosome-associated Chk1

Area of Science:

• Genetics and Developmental Biology
• Cell Biology
• Molecular Medicine

Background:

• Primary microcephaly, Seckel syndrome, and MOPD II are characterized by severe microcephaly, indicating impaired fetal neuron production.
• While primary microcephaly links to microcephalin (MCPH1) mutations, Seckel syndrome and MOPD II involve mutations in ATR or pericentrin (PCNT), disrupting ATR signaling.

Purpose of the Study:

• To investigate the molecular mechanisms linking MCPH1 and PCNT to centrosome function and cell cycle regulation in microcephaly-related disorders.
• To elucidate how defects in MCPH1 or PCNT impact Chk1 localization and cyclin B-Cdk1 activity at centrosomes.

Main Methods:

• Utilized cell models deficient in MCPH1 or PCNT.
• Assessed Chk1 localization at centrosomes using immunofluorescence.
• Analyzed the activation status of centrosomal cyclin B-Cdk1.

Main Results:

• Loss of MCPH1 or PCNT leads to the dissociation of Chk1 from centrosomes.
• This Chk1 loss results in the aberrant activation of centrosomal cyclin B-Cdk1.
• These molecular events contribute to the reduced neuron production observed in these microcephaly disorders.

Conclusions:

• MCPH1 and PCNT are crucial for maintaining Chk1 at centrosomes, ensuring proper cell cycle control.
• Disruption of this pathway underlies the pathogenesis of Seckel syndrome, MOPD II, and potentially other forms of microcephaly.
• Targeting centrosome-mediated cell cycle regulation may offer therapeutic avenues for these developmental disorders.